Events

SEMINAR DESCRIPTION

While several pharmacotherapies have been developed for substance use disorders (SUD) in adults, relatively few have been studied in adolescents, and complex design and execution issues must be addressed to optimize the potential impact of current and future research in this important area. This one-hour presentation will discuss method, design, and key strategies for the optimization of conduct/execution, overall treatment adherence, participant enrollment and retention, documentation, and management of adverse events for adolescent SUD pharmacotherapy trials. With adequate understanding of challenges and opportunities in the design and conduct of these trials, attendees will be equipped to incorporate this information into their research practices.

LEARNING OBJECTIVES

• Identify key issues in the conceptualization/design of pharmacotherapy trials for adolescent substance use disorders (SUD).
• Understand methods to optimize the management/execution of pharmacotherapy trials for adolescent SUD.
• Consider strategies to standardize design methods across adolescent SUD pharmacotherapy trials.

TARGET AUDIENCE

Everyone is welcome! This webinar is targeted to all investigators, clinicians, statisticians, and research staff engaged in the planning and development of pharmacotherapy trials.

About the Presenter

Kevin M. Gray, MD
Dr. Gray is Professor and Director of Child and Adolescent Psychiatry at the Medical University of South Carolina in Charleston, South Carolina. Dr. Gray maintains active clinical practice and conducts National Institutes of Health sponsored clinical research on substance use disorders in adolescents and young adults, with particular emphasis on treatment development for cannabis and tobacco use disorders in youth. With a multidisciplinary group of collaborators, Dr. Gray investigates biobehavioral mechanisms underlying substance use disorders, and works to apply these findings to real world clinical practice.